DXN Holdings Bhd. (KLSE:DXN)
Malaysia · Delayed Price · Currency is MYR 0.4590
-0.004935 (-1.06%)
At close: Aug 11, 2026
DXN Holdings Bhd. Revenue
DXN Holdings Bhd. had revenue of 448.39M MYR in the quarter ending May 31, 2026, a decrease of -7.97%. This brings the company's revenue in the last twelve months to 1.89B, down -2.55% year-over-year. In the fiscal year ending February 28, 2026, DXN Holdings Bhd. had annual revenue of 1.93B, down -0.30%.
Revenue (ttm)
1.89B
Revenue Growth
-2.55%
P/S Ratio
1.22
Revenue / Employee
497.16K
Employees
3,805
Market Cap
2.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 1.93B | -5.76M | -0.30% |
| Feb 28, 2025 | 1.94B | 115.71M | 6.36% |
| Feb 29, 2024 | 1.82B | 203.21M | 12.56% |
| Feb 28, 2023 | 1.62B | 354.43M | 28.06% |
| Feb 28, 2022 | 1.26B | 196.16M | 18.39% |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Duopharma Biotech Berhad | 916.83M |
| Y.S.P. Southeast Asia Holding Berhad | 363.14M |
| Rhone Ma Holdings Berhad | 227.46M |
| Kotra Industries Berhad | 224.41M |
| PeterLabs Holdings Berhad | 131.58M |
| Sunzen Group Berhad | 88.47M |
| Nova Wellness Group Berhad | 47.28M |
| Bioalpha Holdings Berhad | 11.39M |